ClinicalTrials.gov
ClinicalTrials.gov Menu

Association of Transcutaneous Electrical Nerve Stimulation and Hypnosis (HYPTENS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01944150
Recruitment Status : Completed
First Posted : September 17, 2013
Last Update Posted : August 3, 2017
Sponsor:
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

September 2, 2013
September 17, 2013
August 3, 2017
September 2013
February 2017   (Final data collection date for primary outcome measure)
Pain intensity [ Time Frame: between the first visit and three months after the beginning of the strategy. ]

The pain assessment is processed using a Visual Analog Scale (VAS), graduated from 0 to 100mm.

The patient is asked to move a cursor on a line to reflect the severity of his/her pain. The left end indicates "no pain", the right one shows "the most intense pain you can imagine".

On the other side, graduations are only seen by the caregiver. The pain intensity is read on this side, rated in millimetres.

Same as current
Complete list of historical versions of study NCT01944150 on ClinicalTrials.gov Archive Site
  • the patient's observance with the different strategies using a pad. [ Time Frame: from one week after the beginning of the strategy up to 6 months. ]
    Collections of the data (number and duration of TENS device uses) from the patient log book
  • the consumption of analgesic [ Time Frame: during 6 months. ]
    Collection of the concomitant treatments (processing) on the patient pad in every visit.
  • the quality of life estimated by the patient using the scale(ladder) SF36 and estimating the impression(printing) of change of the patient using the PGIC scale(ladder) [ Time Frame: at the first visit, one month, three and six months after the beginning of the strategy, except the scale QDSA, which is used one, three and six months later after the beginning of the strategy. ]

    These two scales are self-assessment, exploring physical, emotional and social health.

    They allow pain impact assessment or professional activities, leisure activities and everyday life.

    The final aim is to identify if patients could recover their usual activity faster in one arm of the study versus the other one.

Same as current
Not Provided
Not Provided
 
Association of Transcutaneous Electrical Nerve Stimulation and Hypnosis
Interest of the Association of Two Complementary Techniques, Hypnosis and Transcutaneous Electrical Nerve Stimulation in the Treatment of Chronic Non-cancer Pain, Nociceptive and / or Neuropathic Pain: Randomized Trial
At Saint-Antoine's hospital, in CETD a multidisciplinary team takes care of patients with chronic pain. Free-drug techniques are available to reduce their consumption of analgesics. This study is to assess the relief obtained by the simultaneous combination of these two techniques: transcutaneous electrical nerve stimulation and hypnosis.

In the pain management centers, patients with chronic pain are supported by a multidisciplinary team. To optimize and reduce drug intake of analgesics, additional techniques (hypnosis, relaxation, cognitive behavioral therapy) and non-drug practices (transcutaneous electrical nerve stimulation) are offered to patients.

These techniques are most frequently performed by nurses and are used either separately or successively. The time interval during what the patient could expect pain relief is not known.

The hypothesis of the study is that simultaneous practice of two complementary therapies (transcutaneous electrical nerve stimulation (TENS) + hypnosis) decreases the intensity of pain in patients with chronic no cancer pain, nociceptive and/or neuropathic pain compared to practice of only one complementary therapy (TENS).

This study is an open randomized trial, comparative in two parallel groups (TENS versus TENS and hypnosis).

Trial design will be explained by the pain management center doctor. Inclusion and randomization performed by the nurse: group with TENS/group with TENS and hypnosis.

The patients will be followed up 8 times between day 0 and day180. Patients benefit from eight visits from day 0th to day 180th. Evaluations are EVA at each visit, SF36 questionnaires and score PGIC at one month, three and six months after the beginning of the strategy.

Interventional
Not Applicable
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
  • Limbs Arthrosis
  • Non Arthrosic Limbs Arthralgia
  • Chronic Lomboradiculalgia
  • Chronic Back Pain
  • Cervical Radiculopathy
  • Post-herpetic Neuralgia
  • Post-surgical Peripheral Neuropathic Pain
  • Post Trauma Neuropathic Pain
  • Complex Regional Pain Syndrome Type I or II
  • Tendinopathy
  • Behavioral: Transcutaneous electrical nerve stimulation
    explanations about devices and their use are given to the patient during the first session. The right place where the electrodes should be placed on, the most effective programme (optimal electric frequency provided by the machine), intensity are tested by the nurse during 30 minutes lasting session
  • Behavioral: Transcutaneous electrical nerve stimulation and hypnosis
    explanations about devices and their use are given to the patient during the first session. The right place where the electrodes should be placed on, the most effective programme (optimal electric frequency provided by the machine), intensity are tested by the nurse. Following informations are collected by the second nurse: pain representation and its relief thoughts about a quiet place. TENS and hypnosis are associated in a unique 30 minutes session
  • Active Comparator: TENS
    Patients with only transcutaneous electrical nerve stimulation (TENS),
    Intervention: Behavioral: Transcutaneous electrical nerve stimulation
  • Experimental: TENS and hypnosis.
    Patients with transcutaneous electrical nerve stimulation (TENS) and hypnosis simultaneously
    Intervention: Behavioral: Transcutaneous electrical nerve stimulation and hypnosis
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
72
Same as current
May 2017
February 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients from 18 to 80 years suffering from chronic no cancer pain either nociceptive or neuropathic.
  • The treated skin must not be wounded
  • The patients must be able to comply with the requirement of the trial; they also need to express no objection to participate to this trial.
  • Patient with social security

Exclusion Criteria:

  • Patients with fibromyalgia, or having relaxation therapy sessions, acupuncture, cognitive and behavioral therapies
  • Patients with cognitive disorders, an unaided hearing loss, a major hearing impairment, carrying a pace maker, having an allodynia or a complete anesthesia of the painful territory, a large spreader painful territory
  • Sessions TENS practiced for analgesic by a professional within 3 years prior to inclusion, for the same pain (same features, same location)
  • Renting at home a TENS device within 3 years prior to inclusion for analgesic
  • Prior therapeutic care by hypnosis
  • pregnant woman or having a desire of pregnancy
Sexes Eligible for Study: All
18 Years to 80 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
France
 
 
NCT01944150
K121201
PHRI120049 ( Other Identifier: Assistance Publique )
No
Not Provided
Not Provided
Assistance Publique - Hôpitaux de Paris
Assistance Publique - Hôpitaux de Paris
Not Provided
Principal Investigator: Louise GEOFFROY, Nurse Assistance Publique - Hôpitaux de Paris
Assistance Publique - Hôpitaux de Paris
August 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP